title: Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis.
authors.forename: Alex
authors.initials: A
authors.lastname: Straumann
authors.forename: Christian
authors.initials: C
authors.lastname: Bussmann
authors.forename: Sébastien
authors.initials: S
authors.lastname: Conus
authors.forename: Christoph
authors.initials: C
authors.lastname: Beglinger
authors.forename: Hans-Uwe
authors.initials: HU
authors.lastname: Simon
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D004804:Eosinophils / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D004847:Epithelial Cells / Q000166:cytology / Q000276:immunology / Q000378:metabolism; D004941:Esophagitis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D004947:Esophagus / Q000276:immunology / Q000473:pathology; D006801:Humans; D000069285:Infliximab; D007958:Leukocyte Count; D008297:Male; D010865:Pilot Projects; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000276:immunology* / Q000378:metabolism
chemical_list: D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab